Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT06203548 Sponsor: Chinese University of Hong Kong Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT06203548
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • A liver scan (MRI) has shown that fat makes up 5% or more of your liver tissue.
  • You have at least one of the following metabolic health factors: a BMI of 23 or higher; a waist measurement of 90 cm or more (men) or 80 cm or more (women); high fasting blood sugar, high blood sugar after eating, high HbA1c, known diabetes, or taking medication for type 2 diabetes; high blood pressure or taking medication for it; high triglycerides (a type of fat in the blood) or taking medication for abnormal cholesterol/fats; or low "good" (HDL) cholesterol or taking medication for abnormal cholesterol/fats.
  • You are willing and able to sign a written consent form agreeing to take part in the study.

Who may not be able to join:

  • You have tested positive for hepatitis B or hepatitis C, or have a history of other liver diseases.
  • You drink more than 30 grams of alcohol per day (if male) or more than 20 grams per day (if female) — roughly 2–3 standard drinks per day (confirm with trial site).
  • Your liver is not functioning well, shown by certain abnormal blood test results or a history of fluid build-up in the abdomen, swollen veins in the food pipe, or confusion caused by liver problems.
  • You are unable to have an MRI scan — for example, because of severe claustrophobia or having certain metal implants in your body.
  • You have been diagnosed with, or currently have, liver cancer.
  • You have had another type of cancer in the past, unless you have been in full remission for more than 5 years.
  • You have previously had a liver transplant or surgery to remove part of your liver.
  • You have other serious health conditions that would likely make it difficult for you to take part in lifestyle activities or attend follow-up appointments during the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +85235054205

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 February 2024
Est. completion
31 January 2027

Where this trial is recruiting

Hong Kong

Primary endpoints

MRI-PDFF response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov